⚓Is Your Research Stalling Without the Right Genetic Models?
😖The quest for precise genetic models is critical for groundbreaking discoveries and innovative solutions, but finding the right models can be daunting.
🌹 Demà és #SantJordi! Envia roses solidàries i fes possible que els nostres pacients no es quedin sense!
❓ Saps que estan fetes per @ArrelsFundacio? Col·labores amb el programa Hospital Amable i a fer que la recerca avanci. #MésQueUnaRosa
Envia! 👇
https://t.co/KWlAZAlok5
Amb profunda tristesa, lamentem comunicar la mort aquesta passada matinada del Dr. Joan Guinovart, fundador, exdirector, exinvestigador i professor emèrit de l’IRB Barcelona.
El Dr. Guinovart ha estat una figura clau en l’àmbit de la bioquímica, deixant una empremta inesborrable tant a nivell científic com de gestió. La seva intel.ligència, lideratge i el seu profund humanisme han estat fonamentals per a les persones que hem tingut la sort de compartir camí amb aquest home irrepetible i per al món de la recerca.
Expressem el nostre més sentit condol a la seva família, amics, companys i a tota la comunitat de l'IRB Barcelona.
Joan, la teva absència ens deixa un gran buit, però el teu llegat perdurarà per sempre.
Et recordarem sempre, capità.
@IRBBarcelona@MolecularOcean Una figura sempre propera als estudiants, divulgador nat, gran conversador i una peça clau per entendre part de la gestió de la ciència que avui es fa a Catalunya. El nostre condol a familiars i amics. D.E.P.
La @COSCEorg presentó ayer el Séptimo Informe Anual 2024 del Acuerdo COSCE de transparencia sobre el uso de animales de experimentación científica en España elaborado por @The_EARA@The_EARA.
El informe analiza la transparencia en experimentación animal de las 168 instituciones adheridas durante el año 2023.
📄 https://t.co/CIhM1IkAov
🧵Síntesis de prensa:
La comisión @COSCEorg de Transparencia sobre el uso de animales en investigación científica acaba de presentar su informe anual https://t.co/XvOahPEcSp
Hace unos días os contábamos que el Grupo Uvesco había vuelto a confiar en nosotros para ser una de las asociaciones beneficiarias de su convocatoria solidaria “Nos cuidamos”. Pues queremos compartir con todos vosotros que hemos sido el proyecto ¡¡GANADOR!!
En ZeCardio Therapeutics, tenemos una misión: transformar la vida de millones de personas afectadas por enfermedades cardiovasculares. Nuestro equipo ha desarrollado una molécula que podría cambiar el futuro de la medicina regenerativa!
✅Develop models for specific patient mutations in record time
✅Discover the clinical relevance of specific mutations with efficiency
✅Identify the optimal treatment for each unique genetic profile with high-throughput drug screenings
🖥 Join our webinar
https://t.co/oZqwHpsT0N
Is Early Gene Therapy Screening Slowing Down Your Research?
Speed Up the Early Selection of Your Best Minigene Candidates with Ease.
Register for our FREE WEBINAR to learn how we can help you: https://t.co/oZqwHpsT0N
ZeClinics is participating in the #OECD Workshop on "Critical Innovations in Pesticides Safety Testing and Chemical Risk Assessment for Developmental Neurotoxicity (DNT)" from today to October 30th, at the OECD headquarters in Paris.
🐟 Zebrafish: The next leap in drug discovery.
Unlock faster, cost-effective insights with whole-organism data. Discover how zebrafish streamline early-stage screening.
👉 Read more in our latest BLOG: https://t.co/xXwBx1qrCe
WEBINAR: From Vision to Strategy! Refine Your Early-Stage Drug Screening
Learn a transformative approach that will help you slash costs and accelerate preclinical drug screenings, while increasing success rates in your predictions.
Register: https://t.co/oZqwHpsT0N
Discover how these challenges can be addressed in our latest article: "Dealing With The Challenges Of Drug Discovery".
Read the full article here! 👉 https://t.co/yj2CL75xBc
In the pharmaceutical and biotech industries, the reality is stark:
🔴Preclinical costs ranging between $1 - $6 million.
🔴1 to 6 years of preclinical development.
🔴Only ~10% of drug candidates successfully transition from preclinical to clinical trials
If you work in this field, you likely feel the weight of these statistics firsthand.
Is the traditional drug discovery process holding back your pipeline?
What obstacle do you feel impacts your preclinical drug discovery process the most?
💡Understanding these advancements is key to unlocking new potentials in biomedical research and drug development. If you’re passionate about biomedicine, bioinformatics, or technological innovation, this article is a must-read!
➡️ Check it out here: https://t.co/oHVHtM52kQ
In biomedical research, effective data management is crucial. It drives the accuracy of discoveries, accelerates innovation, and ensures that complex biological data is used to its fullest potential. We've just published an article that dives deep into how this field has evolved!
To #KnowledgeGraphs: The next frontier in data integration, offering a dynamic and intuitive way to capture and analyze complex relationships, transforming the way we approach target identification and drug discovery.